Who owns BRIDGEBIO PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Bridgebio Pharma stock

Who bought or sold BRIDGEBIO PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
D. E. Shaw & Co 63M $107M 100% Mar 2026
 View chart
Franklin Resources 59M $100M 100% Mar 2026
 View chart
OZ Management 40M $68M 100% Mar 2026
 View chart
Invesco 29M $50M 100% Mar 2026
 View chart
BlackRock 24M $40M 100% Mar 2026
 View chart
Nuveen 21M $35M 100% Mar 2026
 View chart
CSS 10M $17M 100% Mar 2026
 View chart
Alberta Investment Management Corporation 10M $17M 100% Mar 2026
 View chart
Calamos Advisors 8.1M $14M 100% Mar 2026
 View chart
Ameriprise Financial 6.0M $10M 100% Mar 2026
 View chart
Wolverine Asset Management 5.6M $9.6M 100% Mar 2026
 View chart
SSI Investment Management 4.1M $7.0M 100% Mar 2026
 View chart
Bank of America Corporation 3.5M $6.0M 100% Mar 2026
 View chart
Goldman Sachs Group 2.7M $4.7M 100% Mar 2026
 View chart
Bnp Paribas Arbitrage, Snc 1.7M $2.8M 100% Mar 2026
 View chart
Universal- Beteiligungs- und Servicegesellschaft mbH 1.4M $2.4M 100% Mar 2026
 View chart
683 Capital Management 1.0M $1.7M 100% Mar 2026
 View chart
Lazard Asset Management 843k $14k 100% Mar 2026
 View chart
Jane Street 700k $1.2M 100% Mar 2026
 View chart
Wells Fargo & Company 677k $1.2M 100% Mar 2026
 View chart
Millennium Management 500k $849k 100% Mar 2026
 View chart
Ares Systematic Credit 300k $486k 100% Mar 2026
 View chart
Deutsche Bank Aktiengesellschaft 298k $505k 100% Mar 2026
 View chart
Man Group 225k $382k 100% Mar 2026
 View chart
Bank of New York Mellon 200k $340k 100% Mar 2026
 View chart
Wellesley Investment Advisors 125k $213M 100% Mar 2026
 View chart
Persistent Asset Partners 60k $102k 100% Mar 2026
 View chart
ADAR1 Capital Management 30k $4.9M 100% Mar 2026
 View chart